In vivo animal studies with sugammadex.
until further notice
SourceAnaesthesia, 64 Suppl 1, 1, (2009), pp. 38-44
Article / Letter to editor
Display more detailsDisplay less details
vol. 64 Suppl 1
SubjectDCN 1: Perception and Action
A review is presented of animal studies of the selective steroidal neuromuscular blocking drug binding agent sugammadex. These studies demonstrate that sugammadex is faster in onset than the currently used acetylcholinesterase inhibitors, has no muscarinic effects, and is characterised by lack of adverse effects on other organs. These results offer support for the further development of sugammadex for clinical use in humans.
Upload full text
Use your RU credentials (u/z-number and password) tolog in with SURFconextto upload a file for processing by the repository team.